05/02/2025 3:17 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 3:58 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2025 3:09 PM | Centessa Pharmaceuticals (Subject) HUSSAIN IQBAL J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/25/2025 7:20 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2025 4:43 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2025 3:46 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2025 3:59 PM | Centessa Pharmaceuticals (Filer)
| Form PRE 14A | |
04/21/2025 3:14 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/24/2025 6:31 AM | Centessa Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/24/2025 6:11 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2025 3:53 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CNTA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
03/20/2025 3:08 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 3:47 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 3:47 PM | Centessa Pharmaceuticals (Issuer) CHAO DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 3:45 PM | Centessa Pharmaceuticals (Subject) HUSSAIN IQBAL J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025 3:25 PM | Centessa Pharmaceuticals (Subject) CHAO DAVID M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025 4:45 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 4:59 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 4:33 PM | Anderson Karen M. (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 3:14 PM | Anderson Karen M. (Reporting) Centessa Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025 3:55 PM | Centessa Pharmaceuticals (Issuer) CHAO DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 3:55 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 3:55 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 3:56 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 3:56 PM | Anderson Karen M. (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 3:56 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 3:57 PM | Centessa Pharmaceuticals (Issuer) Kanes Stephen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 3:57 PM | Centessa Pharmaceuticals (Issuer) Crowley John J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/03/2025 3:08 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025 3:04 PM | Anderson Karen M. (Reporting) Centessa Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025 3:32 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:07 PM | Centessa Pharmaceuticals (Subject) Weinhoff Gregory M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025 3:16 PM | Centessa Pharmaceuticals (Issuer) Kanes Stephen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/08/2025 6:00 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/31/2024 3:30 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/31/2024 3:31 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/31/2024 3:32 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/31/2024 3:32 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/31/2024 3:33 PM | Centessa Pharmaceuticals (Issuer) CHAO DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/30/2024 4:28 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2024 5:10 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) While everyone's distracted by Bitcoin's moves, a stealth revolution is underway.
One altcoin is quietly positioning itself to overthrow the entire banking system. Click here to access the full report now. |
12/20/2024 4:22 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 3:18 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024 4:09 PM | Anderson Karen M. (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 4:10 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 4:11 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 3:02 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 3:14 PM | Centessa Pharmaceuticals (Subject) HUSSAIN IQBAL J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 4:03 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2024 3:14 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 3:03 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 3:07 PM | Centessa Pharmaceuticals (Subject) Weinhoff Gregory M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024 4:06 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 3:33 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024 3:30 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 4:43 PM | Centessa Pharmaceuticals (Subject) EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024 6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 6:16 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024 6:19 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2024 3:10 PM | Centessa Pharmaceuticals (Subject) Weinhoff Gregory M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024 4:27 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2024 3:07 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024 3:15 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024 3:01 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/27/2024 3:15 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 3:01 PM | Centessa Pharmaceuticals (Subject) Weinhoff Gregory M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024 3:55 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 7:01 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 7:01 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 3:40 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2024 3:01 PM | Centessa Pharmaceuticals (Filer)
| Form S-3ASR | |
09/10/2024 3:04 PM | Centessa Pharmaceuticals (Subject) Weinhoff Gregory M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 3:06 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/09/2024 4:06 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 4:12 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 4:13 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 3:19 PM | Centessa Pharmaceuticals (Subject) Weinhoff Gregory M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024 4:15 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 3:32 PM | Centessa Pharmaceuticals (Subject) Weinhoff Gregory M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024 3:13 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024 3:38 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 3:52 PM | Centessa Pharmaceuticals (Subject) SAHA SAURABH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 6:27 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 3:30 PM | Centessa Pharmaceuticals (Issuer) Crowley John J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 3:31 PM | Bush Tia L (Reporting) Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 3:32 PM | Centessa Pharmaceuticals (Issuer) Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:30 PM | Centessa Pharmaceuticals (Issuer) ZBAR BRETT I W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:31 PM | Centessa Pharmaceuticals (Issuer) Stuckley Carol (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:32 PM | Centessa Pharmaceuticals (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Elon’s Terrifying Warning Forces Trump To Take Action (Ad) Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history.
Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are... Get your free gold guide! |
06/27/2024 3:33 PM | Centessa Pharmaceuticals (Issuer) Hukkelhoven Mathias (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:34 PM | Centessa Pharmaceuticals (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:34 PM | Centessa Pharmaceuticals (Issuer) GOYAL ARJUN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:14 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 7:49 PM | Centessa Pharmaceuticals (Issuer) Crowley John J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/10/2024 6:13 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 7:48 PM | Centessa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/13/2024 3:32 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 7:00 AM | Centessa Pharmaceuticals (Filer)
| Form DEF 14A | |